Adjuvant chemotherapy for surgically resected non–small cell lung cancer

Volume: 144, Issue: 3, Pages: S39 - S42
Published: Sep 1, 2012
Abstract
Despite surgical resection, patients with early-stage (I to IIIA) non–small cell lung cancer (NSCLC) are at considerable risk of recurrence and death from their lung cancer. In recent years, multiple, large, randomized trials assessing the efficacy of adjuvant chemotherapy for resected NSCLC have been reported. Three of 6 trials with 300 or more patients with early-stage NSCLC have demonstrated that adjuvant cisplatin-based chemotherapy can...
Paper Details
Title
Adjuvant chemotherapy for surgically resected non–small cell lung cancer
Published Date
Sep 1, 2012
Volume
144
Issue
3
Pages
S39 - S42
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.